Skip to main content

UBS Group AG

Position in APVO — Aptevo Therapeutics Inc.

CIK 1610520 ZURICH, V8

Position in APVO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,240
-$11,470 QoQ
Shares Held
730
-78.8% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 9 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APVO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,271,661 across 562 Biotechnology names. APVO ranks #483 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in APVO

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,240 730
2026-03-31 $14,710 3,445
2025-12-31 $1,602 170
2025-09-30 $8,225 5,673
2024-12-31 $3,374 783
2024-09-30 $0 1
2024-06-30 $35,468 115,910
2023-12-31 $1 5
2023-09-30 85
2022-12-31 1,430
2022-09-30 430
2022-06-30 1,107
2021-12-31 3,212
2021-06-30 1,821
2020-12-31 311
2020-09-30 8,848
2020-06-30 10,015
2020-03-31 11,548